Anthera Pharmaceuticals, Inc. (ANTH) Posts Q3 Loss of 17c/Share

October 24, 2012 5:03 PM

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) reported Q3 EPS of ($0.17) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found